The Community Engagement Core (CEC) aims to develop, implement, and evaluate a community-based infrastructure to maintain the link between MHDRC researchers and the targeted communities. The ultimate goal is to enhance minority participation in research by building community capacity and engaging the community in the development and implementation processes of research studies. The objectives of the CEC will be accomplished using the principles of Community-Based Participatory Research (CBPR) and the Empowerment Model. The leaders of the CEC are established partners of the targeted communities, and the Core will build on the success of the community and institutional capacities developed during Phases I and II of the MHDRC and through other UAB programs in health disparities. The specific alms are: 1) Establish a coalition that will lead to effective partnerships between the community and investigators from MHDRC and UAB;2) Promote capacity building in the targeted communities by educating and empowering the community constituents, such as community-based organizations and church representatives, and by establishing networks of trained community volunteers;3) Develop a culturally appropriate plan to enhance the recruitment and retention of minorities in research studies related to health disparities (diabetes, cancer, CVD, etc.), with emphasis on underserved groups;4) Engage community partners in the application and dissemination of findings from relevant evidence-based research projects in diabetes, cancer prevention and control, and CVD risk factors, such as obesity and hypertension;5) Provide training and education for investigators and staff on the best practices for conducting research in racial/ethnic minority communities, with emphasis on cultural competency, bioethics, risk assessment, behavioral change, and CBPR principles. Significance. The Core builds on a strong community infrastructure that was established during the previous two phases of the P60 COE - MHDRC. It continues and expands our previous work that led to understanding of the socio-cultural factors associated with barriers of minority participation in clinical research. It takes into account the cultural perspectives of the targeted audience in the program development, using formative assessments. The communities will benefit by participating in dialogue with MHDRC investigators about the research agenda, and from the dissemination of evidence-based practices. MHDRC investigators will realize enhanced minority participation in research studies, greater community buy-in to the research agenda of the MHDRC, and clearer routes of dissemination and intervention sustainability.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Comprehensive Center (P60)
Project #
2P60MD000502-10
Application #
8346004
Study Section
Special Emphasis Panel (ZMD1-RN (02))
Project Start
2012-09-20
Project End
2017-03-31
Budget Start
2012-09-20
Budget End
2013-03-31
Support Year
10
Fiscal Year
2012
Total Cost
$206,805
Indirect Cost
$65,608
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Boehme, Amelia K; Siegler, James E; Mullen, Michael T et al. (2014) Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 23:e255-61
Boehme, Amelia K; Rawal, Pawan V; Lyerly, Michael J et al. (2014) Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt. J Stroke Cerebrovasc Dis 23:2001-6
Petrov, Megan E; Sawyer, Patricia; Kennedy, Richard et al. (2014) Benzodiazepine (BZD) use in community-dwelling older adults: Longitudinal associations with mobility, functioning, and pain. Arch Gerontol Geriatr 59:331-7
Petrov, Megan E; Howard, Virginia J; Kleindorfer, Dawn et al. (2014) Over-the-counter and prescription sleep medication and incident stroke: the REasons for Geographic and Racial Differences in Stroke study. J Stroke Cerebrovasc Dis 23:2110-6
Chang, Tiffany R; Albright, Karen C; Boehme, Amelia K et al. (2014) Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state. Clin Appl Thromb Hemost 20:124-8
Mullen, Michael T; Wiebe, Douglas J; Bowman, Ariel et al. (2014) Disparities in accessibility of certified primary stroke centers. Stroke 45:3381-8
Lyerly, Michael J; Houston, J Thomas; Boehme, Amelia K et al. (2014) Safety of intravenous tissue plasminogen activator administration with computed tomography evidence of prior infarction. J Stroke Cerebrovasc Dis 23:1657-61
Boehme, Amelia K; Kapoor, Niren; Albright, Karen C et al. (2014) Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator. J Stroke Cerebrovasc Dis 23:e271-6
Mathias, Tiffany L; Albright, Karen C; Boehme, Amelia K et al. (2014) The Impact of Myocardial Infarction vs. Pneumonia on Outcome in Acute Ischemic Stroke. J Cardiovasc Dis 2:1-3
Petrov, Megan E; Kim, Yongin; Lauderdale, Diane S et al. (2014) Objective sleep, a novel risk factor for alterations in kidney function: the CARDIA study. Sleep Med 15:1140-6

Showing the most recent 10 out of 28 publications